SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-024625
Filing Date
2017-12-06
Accepted
2017-12-06 17:11:13
Documents
7
Period of Report
2017-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOC-8K-20171206 bioc-8k_20171205.htm 8-K 38316
2 EX-5.1 bioc-ex51_9.htm EX-5.1 15174
3 EX-10.1 bioc-ex101_8.htm EX-10.1 218854
4 EX-10.2 bioc-ex102_6.htm EX-10.2 146080
5 EX-99.1 bioc-ex991_7.htm EX-99.1 15137
6 GRAPHIC g2017120621303846723.jpg GRAPHIC 28720
7 GRAPHIC g2017120621305039431.jpg GRAPHIC 7292
  Complete submission text file 0001564590-17-024625.txt   484582
Mailing Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 330757995 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 171242913
SIC: 8071 Services-Medical Laboratories